Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Kendle Names Early Stage Executive | Contract Pharma

What are you searching for?

Sign in
Breaking News, Promotions & Moves

Kendle Names Early Stage Executive

Pierre Geoffroy, M.D., CM, MSc, FCFP has been appointed vice president of Early Stage at Kendle.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Pierre Geoffroy, M.D., CM, MSc, FCFP has been appointed vice president of Early Stage at Kendle. Dr. Geoffroy will oversee the development of early stage programs for customers worldwide, providing medical expertise and clinical insights for the development of early stage clinical trials. Dr. Geoffroy will be based at the company’s Early Stage unit in Toronto and will report to Kendle’s president and chief executive officer Stephen Cutler, Ph.D.

Dr. Geoffroy joins the company from Lambda Therapeutic Research, where he most recently served as chief medical officer, vice president and principal investigator. He also has served in senior clinical roles at multiple global biopharmaceutical companies, including Sanofi Pasteur, Wyeth Ayerst K.K., Wyeth Research Canada, Hoffmann La Roche and SmithKline Beecham.

“We are thrilled to welcome Dr. Geoffroy to Kendle,” said Dr. Cutler. ”He brings extensive expertise in early stage development to assist our customers in making strategic decisions related to the future of their compounds. We look forward to his leadership as we focus on positioning Kendle’s Early Stage operations for growth.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics